Tianjin Tairuibosi Medical Instruments Co., Ltd. – Trademark Portfolio

Entity Type: 99

Tianjin Tairuibosi Medical Instruments Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TAIRIBOUSY. The owner is based in Beichen Dist., Tianjin.

No.29, Jingbao Industrial Zone

Beichen Dist., Tianjin 300401 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Tianjin Tairuibosi Medical Instruments Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Tianjin Tairuibosi Medical Instruments Co., Ltd. have?

Tianjin Tairuibosi Medical Instruments Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Tianjin Tairuibosi Medical Instruments Co., Ltd. file in?

Tianjin Tairuibosi Medical Instruments Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Tianjin Tairuibosi Medical Instruments Co., Ltd.'s most well-known trademarks?

Tianjin Tairuibosi Medical Instruments Co., Ltd.'s registered trademark portfolio includes well-known marks such as TAIRIBOUSY. These are among 1 currently registered trademark in the portfolio.

What is Tianjin Tairuibosi Medical Instruments Co., Ltd.'s trademark registration success rate?

Tianjin Tairuibosi Medical Instruments Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.